DaVita Inc.’s Stock Price Skyrockets to $151.90, Witnessing a Stellar Rise of 3.32%

DaVita Inc. (DVA)

151.90 USD +4.88 (+3.32%) Volume: 1.48M

DaVita Inc.’s stock price is currently performing well at 151.90 USD, showing a promising increase of +3.32% this trading session with a trading volume of 1.48M. Demonstrating steady growth, the stock has also experienced a year-to-date percentage change of +1.57%, making DVA a potential contender in the market.

Latest developments on DaVita Inc.

Mutual of America Capital Management LLC recently sold 281 shares of DaVita Inc. (NYSE:DVA), a move that could potentially impact the stock price today. This sell-off comes amidst various market factors and internal company developments that have been influencing DaVita’s stock performance. Investors are closely monitoring these events to gauge the future direction of the stock price, making it a volatile period for DaVita shareholders.

A look at DaVita Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

DaVita Inc., a company that offers healthcare services, has a mixed outlook according to Smartkarma Smart Scores. While it scores well in growth and momentum, with a score of 4 for both factors, its value and resilience scores are lower at 2. The company’s dividend score is the lowest at 1. This indicates that DaVita may have strong potential for growth and positive market momentum, but may not be as strong in terms of value and resilience.

DaVita Inc. provides a range of healthcare services, particularly focusing on kidney dialysis for patients with chronic kidney failure. With a global reach, the company’s Smartkarma Smart Scores show a positive outlook for growth and momentum, scoring 4 in both categories. However, its value and resilience scores are lower at 2. Additionally, DaVita’s dividend score is the lowest at 1. This suggests that while the company may see strong growth and market momentum in the long term, investors should be cautious of its value and resilience factors.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma